Adequacy of reporting race/ethnicity in clinical trials in areas of health disparities

This publication has 18 references indexed in Scilit:

• Selection and description of cancer clinical trials participants—Science or happenstance?
  Cancer, 2002
• Participation in Research and Access to Experimental Treatments by HIV-Infected Patients
  New England Journal of Medicine, 2002
• Representation of Elderly Persons and Women in Published Randomized Trials of Acute Coronary Syndromes
  JAMA, 2001
• Enrollment of Women in Cardiovascular Clinical Trials Funded by the National Heart, Lung, and Blood Institute
  New England Journal of Medicine, 2000
• Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
  New England Journal of Medicine, 1999
• How the new NIH guidelines on inclusion of women and minorities apply: Efficacy trials, effectiveness trials, and validity.
  Journal of Consulting and Clinical Psychology, 1996
• Improving the quality of reporting of randomized controlled trials. The CONSORT statement
  JAMA, 1996
• Representation of African-Americans, Hispanics, and Whites in National Cancer Institute Cancer Treatment Trials
  JNCI Journal of the National Cancer Institute, 1996
• Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993 — The perspective of NIH clinical trialists
  Controlled Clinical Trials, 1995
• A proposal for structured reporting of randomized controlled trials. The Standards of Reporting Trials Group
  Published by American Medical Association (AMA) ,1994